Laparoscopic HIFU Ablation 11 mm Probes


Sonasource is a platform technology that provides the foundation for all of SonaCare Medical's focused ultrasound probes.

Sonablate HIFU is the next generation of prostate care.


Utilizing focused ultrasound combined with ultrasound-based imaging and assessment technology, Sonablate provides a minimally invasive approach to delivering precise and focused ablative energy.

Laparoscopic HIFU Ablation 11 mm Probes


Fully integrated multi-transducer technology provides ultrasound images plus precise delivery of high intensity focused ultrasound (HIFU) energy to ablate targeted soft tissue through laparoscopic and other surgical approaches.



Using Sound Energy to Transform the Surgical Landscape

SonaSurgery gives surgeons minimally invasive options for destroying unhealthy tissue with thermal ablation throughout the body. SonaSurgery is a new treatment paradigm that combines elements from radiology, needle ablation and surgery to effectively ablate targeted tissue with minimal impact on a patient's quality of life.
Reduced side effect profiles
Reduced procedure time
Tissue sparing intervention across specialties
More favorable outcomes via "non-cutting" intervention.
Imaging and feedback tools provide live results from targeted area(s)
Increases the number of patients appropriate for surgical intervention

Reduces costs associated with surgical intervention

The Simple 3 Step Process

1. AIM

at specific tissue using ultrasound-MR fusion.

HiFu targeting system for removal of tissue


with pinpoint accuracy while sparing untargeted tissue.

Ablate Prostate cancer with HIFU


using real-time imaging and advanced TCM Technology.

advanced TCM Technology

Sonablate Prostate Ablation

PHYSICIANS & Counting...

Regulatory Statements

Sonablate® has 510(K) clearance in the U.S. and is indicated for the transrectal high intensity focused ultrasound (HIFU) ablation of prostatic tissue. Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.


Sonatherm® laparoscopic HIFU surgical ablation system has 510(K) clearance in the U.S., CE Marking and has obtained regulatory authorization in more than 30 countries outside the U.S. Sonatherm is indicated for the laparoscopic or intraoperative ablation of soft tissue from the ultrasound focal zone back to the surface of the targeted ablation area in General Surgery. Sonatherm is not to be used to spare intervening tissue. Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.


Ready to offer SonaSurgery at your practice or hospital?


HIFU company


10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

Mon - Fri: 9:00 - 5:00

Latest News

26 September 2017

Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017 CHARLOTTE, N.C., Sept. 20, 2017 /PRNewswire/ -- SonaCare...

29 August 2017

CHARLOTTE, N.C., August 30, 2017 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces today the successful collaboration with BK Ultrasound, achieving compatibility...